For months, Lila had been furious that my doctoral research was attracting attention. I had developed a low-cost diagnostic imaging model that could detect certain retinal abnormalities using hardware clinics already owned. It wasn’t glamorous, but it worked. Two hospital systems were discussing pilot programs, and my advisor, Professor Adrian Shaw, had warned me to keep my files private until after the defense.
Lila had never cared about my work until she learned that a medical technology company might license it.
Then she started asking strange questions.
How much could
